You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Novel, Nanostructured, Metal-organic Frameworks-Based Product Loss Prevention Technology in the Oil and Natural Gas Sector
SBC: FRAMERGY INC Topic: 17NCER2CTo reach the end user, oil and gas production at the wellhead must be transmitted through the country and distributed to a wide range of customers. This logistical system requires natural gas gathering lines, processing facilities, product storage tanks and lots of other equipment. What results is air pollution caused by industry losses during these operations and the use of continuous or intermit ...
SBIR Phase I 2018 Environmental Protection Agency -
Formulation and testing of an entirely wood-based exterior insulation board for the high-performance building market
SBC: GO Lab Inc. Topic: 17NCER6BThe goal of this project is the formulation a rigid, insulating, low-density wood composite, with physical and thermal properties comparable to fossil fuel derived foams. _x000D_ _x000D_ To achieve energy conservation standards mandated by certification agencies such as Passive House and LEED, high performance buildings require multiple shells of insulation – an inner shell that contains electri ...
SBIR Phase I 2018 Environmental Protection Agency -
V-Motive: System for Comprehensive Therapy-Integrated Video Modeling
SBC: Experiad LLC Topic: 104DESCRIPTION (provided by applicant): This fast-track SBIR will result in a new type of software system, called V-Motive, which will facilitate the combination of two proven autism behavioral interventions: Applied Behavior Analysis therapy (ABA) and Video Modeling (VM). V-Motive will have the potential to change how ABA therapy is performed by making it feasible for therapy providers to leverage V ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
A High-Throughput, Multi-Omic Assay of Tumor Biomarkers from Single-Cells
SBC: ISOPLEXIS CORPORATION Topic: 172SUMMARY Although solid tumors oftentimes arise from the uninhibited growth of a single aberrant cellthe population of cells within a tumor are genetically and molecularly heterogenousThis makes it very difficult to evaluate a therapy s efficacy when using bulk population measurementsFurthermorerecent research has implicated microRNAsmiRNAsas drivers of progression and malignancy in many tumor type ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of Non-Stigmatizing Hip Protection for Prevention of Fall-Related Injuries
SBC: Alba-Technic, LLC Topic: NIAPROJECT SUMMARY ABSTRACT Hip fracture is one of the most serious fall related injuries in older adultshas a high rate of mortality and higher rate of disabilityThe incidence of hip fractures continues to increase as older adults become a larger proportion of the U SpopulationWithin one year post hip injuryof elderly die andof community dwellers are placed in nursing homesAccordinglyhip injury prev ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Confocal and Autofluorescence Imaging of Macular Degeneration using a Low Cost Digital Imager
SBC: AEON IMAGING LLC Topic: NEIProject SummaryAbstract The overall goal of the proposed SBIR Phase II research is to build and evaluate a low costmulti mode retinal camera used to detect and manage causes of macular impairmentAge related macular degenerationAMDremains the most common cause of permanent vision loss in the US and many industrialized countriesTreatments with portable lasers and injectable drugs can save sightbut e ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
A Novel Glycosaminoglycan-Based Therapeutic for Chronic Rhinosinusitis
SBC: GLYCOMIRA, LLC Topic: NIAIDPROJECT SUMMARY Chronic rhinosinusitis (CRS) is one of the most prevalent inflammatory diseases in the U.S., affecting up to 16% of the population and substantially diminishing the quality of life and productivity of patients. In four years, the annual U.S. health care expenditure to treat patients with CRS dramatically increased from $9B to $64B (5% of the health care budget), with a correspondin ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Enhanced Recovery of Pharmaceutical Solvent driven by EPA Initiative
SBC: COMPACT MEMBRANE SYSTEMS, INC. Topic: NIEHSSummary Enhanced Recovery of Pharmaceutical Solvent driven by EPA InitiativeThe United States Environmental Protection AgencyEPAis establishing new safeguards for hazardous secondary materials with objectives to promote the economicenvironmentaland public health benefits of recycling wasteswith an emphasis on several industrial sectorsincluding the pharmaceutical industryOn averagepharmaceutical m ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Polymeric nanoparticles for inductive browning of white adipose tissue
SBC: ADIPO THERAPEUTICS, LLC Topic: 200Global epidemics of obesity and its associated comorbidities pose formidable challenges to human healthCurrent few medications available for obesity treatment only produce modest effects and are usually accompanied with unpleasantpotentially harmful side effectsThere is accumulating evidence that significant metabolic differences that distinguish beige brown adipocytes from white adipocytes can po ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of novel small molecule analgesics modulating the nNOS-NOS1AP protein-protein interaction
SBC: ANAGIN Topic: 103Abstract This application, “Development of novel small molecule analgesics modulating the nNOS-NOS1AP protein- protein interaction,” addresses the critical need for more effective medications to treat chronic neuropathic pain affecting ~116 million people in the United States. Current pain medications such as NSAIDS, steroids, opiates and gabapentin analogs have documented and often severe sid ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health